维持血液透析的老年患者的抑郁症症状和相关变量
Maurizio Bossola1,2, Laura Angioletti3, Alessia Trotta2,4
1Servizio Emodialisi, Università Cattolica del Sacro Cuore, Rome, Italy.
Journal of renal care
|July 9, 2025
概括
抑郁症在老年血液透析患者中很普遍. 女性性别,透析后疲劳,日常生活的低器械活动和高感知压力与此人群中较高的抑郁症得分有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
- 精神病学是一个精神病学.
背景情况:
- 在接受维持血液透析的患者中,抑郁症很常见.
- 在接受维持血液透析的老年人 (65岁以上) 中,抑郁症的患病率和相关因素不太清楚.
研究的目的:
- 为了确定维持血液透析的老年患者中抑郁症的患病率.
- 在这个人口群体中确定与抑郁症相关的变量.
主要方法:
- 在意大利对197名接受维持血液透析的老年患者 (65-80岁) 进行了横截面研究.
- 抑郁症使用贝克抑郁症目录II (BDI-II) 进行评估.
- 感知压力被测量使用感知压力量表 (PSS),与临床和实验室数据收集一起.
主要成果:
- 34%的患者的BDI-II得分为14或更高,表明显著的抑郁症状.
- 较高的BDI-II得分与女性性别,透析后疲劳,较低的日常生活仪器活动 (IADL) 得分和较高的PSS得分有关.
- 具有较高BDI-II分数的患者报告透析后更强烈,更频繁,更长时间的疲劳,以及更高的严重感知压力的患病率.
结论:
- 在接受维持血液透析的老年患者中,抑郁症与女性性别,IADL受损和感知压力独立相关.
- 在这个群体中,透析后的疲劳是与抑郁症严重程度相关的重要因素.
相关概念视频
Hemodialysis III: Nursing Management
196
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
196
Hemodialysis II: Procedure and Complications
143
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
143
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Peritoneal Dialysis III: Nursing Management
157
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
157
Depressive Disorders: MDD and Dysthymia
224
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
224
Heart Failure VI: Adjunct Therapies
36
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
36


